Advertisement

History: Pancreas

  • Shigeyuki Kawa
  • Takayuki Watanabe
  • Masahiro Maruyama
  • Tetsuya Ito
  • Masafumi Maruyama
  • Yayoi Ozaki
  • Takashi Muraki
  • Hideaki Hamano
  • Norikazu Arakura
Chapter

Abstract

IgG4-related disease (IgG4-RD) has come to be recognized as a systemic disorder characterized by high serum IgG4 concentrations and abundant IgG4-positive plasma cell infiltration in affected organs. Autoimmune pancreatitis (AIP) is a major manifestation of this condition, whose close association with IgG4 has been intensively investigated. In this chapter, we focused on the history of the association between AIP and IgG4, which led to the proposal of the new disease concept of IgG4-RD.

Keywords

Main Pancreatic Duct Autoimmune Pancreatitis Serum IgG4 Concentration Japan Pancreas Society Obliterative Phlebitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kawa S, Fujinaga Y, Ota M, et al. Autoimmune pancreatitis and diagnostic criteria. Curr Immunol Rev. 2011;7:144–61.CrossRefGoogle Scholar
  2. 2.
    Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas–an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–98.PubMedCrossRefGoogle Scholar
  3. 3.
    Nakano S, Takeda I, Kitamura K, et al. Vanishing tumor of the abdomen in patient with Sjoegren’s syndrome. Dig Dis. 1978;23:75–9.CrossRefGoogle Scholar
  4. 4.
    Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387–95.PubMedCrossRefGoogle Scholar
  5. 5.
    Comings DE, Skubi KB, Van Eyes J, et al. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med. 1967;66:884–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Toki F, Kozu T, Oi I, et al. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP-A report of four cases. Endoscopy. 1992;24:640.Google Scholar
  7. 7.
    Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci. 1997;42:1458–68.PubMedCrossRefGoogle Scholar
  9. 9.
    Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Eng J Med. 2001;344:732–8.CrossRefGoogle Scholar
  10. 10.
    Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Kawa S, Sugai S. History of autoimmune pancreatitis and Mikulicz’s disease. Curr Immunol Rev. 2011;7:137–43.CrossRefGoogle Scholar
  12. 12.
    Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas. 2003;27:1–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–27.PubMedCrossRefGoogle Scholar
  15. 15.
    Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552–63.PubMedCrossRefGoogle Scholar
  16. 16.
    Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol. 2009;104:2308–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Otsuki M. Chronic pancreatitis. The problems of diagnostic criteria. Pancreatology. 2004;4:28–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–31.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12:2487–96.PubMedGoogle Scholar
  20. 20.
    Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–6. quiz 934.PubMedCrossRefGoogle Scholar
  21. 21.
    Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas. 2011;40:352–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197–205.PubMedCrossRefGoogle Scholar
  24. 24.
    Yamamoto M, Takahashi H, Sugai S, et al. Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy). Autoimmun Rev. 2005;4:195–200.PubMedCrossRefGoogle Scholar
  25. 25.
    Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.PubMedCrossRefGoogle Scholar
  26. 26.
    Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: Analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2008;68:1310–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4-RD): general concept and details. Mod Rheumatol. 2011;22:1–14.PubMedCrossRefGoogle Scholar
  28. 28.
    Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Shigeyuki Kawa
    • 1
  • Takayuki Watanabe
    • 2
  • Masahiro Maruyama
    • 2
  • Tetsuya Ito
    • 2
  • Masafumi Maruyama
    • 2
  • Yayoi Ozaki
    • 2
  • Takashi Muraki
    • 2
  • Hideaki Hamano
    • 3
  • Norikazu Arakura
    • 4
  1. 1.Center for Health, Safety, and Environmental ManagementShinshu UniversityMatsumoto CityJapan
  2. 2.Department of GastroenterologyShinshu University School of MedicineMatsumoto CityJapan
  3. 3.Department of Medical InformationShinshu University School of MedicineMatsumoto CityJapan
  4. 4.Department of Endoscopic Examination CenterShinshu University School of MedicineMatsumoto CityJapan

Personalised recommendations